2011 Energy Pharmaceuticals Technology 
Harvard Business Review
JUNE 16, 2016
Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. Draetta of IACS has found many of the same issues arise in pharmaceutical research.
Harvard Business Review
MAY 20, 2014
The rate of business formation in 2011 was almost half of what it was in 1978, with the rate of dissolution somewhat higher than the past couple decades. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. Consolidation of the financial sector has led to similar dynamics in other industries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Strategy Driven
JANUARY 24, 2011
Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.
Harvard Business Review
NOVEMBER 20, 2015
But entrepreneurial know-how and energy can work very effectively in the context of plugging-in as a supplier, as Steve Cronce and thousands of others are learning. Global supply chains can cut across many “cultures”: national, industry, technology, market segment, and more.
Harvard Business Review
SEPTEMBER 14, 2011
We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. This lab isn't located in Bangalore or Hyderabad (where Dr Reddy's is headquartered) but in.
Expert insights. Personalized for you.
8 
Let's personalize your content